Journal ArticleOPEN ACCESS

Safety and Efficacy of Belantamab Mafadotin in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience

  • Dileo R
  • Mewawalla P
  • Patrus G
  • et al.
Blood (2024) 144(Supplement 1) 4742-4742
DOI: 10.1182/blood-2024-206059
N/ACitations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Dileo, R., Mewawalla, P., Patrus, G., Strouse, C., Chen, E., Shaikh, H., … Hashmi, H. (2024). Safety and Efficacy of Belantamab Mafadotin in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience. Blood, 144(Supplement 1), 4742–4742. https://doi.org/10.1182/blood-2024-206059

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free